Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Flaxseed Mucilage and Satiety (MUCISAT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2010 by University of Copenhagen.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
University of Copenhagen
ClinicalTrials.gov Identifier:
NCT01238744
First received: November 10, 2010
Last updated: NA
Last verified: August 2010
History: No changes posted

November 10, 2010
November 10, 2010
August 2009
August 2010   (final data collection date for primary outcome measure)
Appetite sensation [ Time Frame: 120 minutes ] [ Designated as safety issue: No ]
Appetite sensation measured by visual analogue scales
Same as current
No Changes Posted
Energy intake [ Time Frame: 120 minutes ] [ Designated as safety issue: No ]
Ad libitum energy intake at the next meal
Same as current
Not Provided
Not Provided
 
Flaxseed Mucilage and Satiety
Effect of Flaxseed Mucilage Drinks and Tablets on Satiety and Energy Intake

The effect of a single dose of flaxseed mucilage incorporated into either drinks or tablets will be tested in term of their effect on appetite sensation measured using visual analogue scales over 120 minutes and ad libitum energy intake hereafter in two studies.

Study I:

Control drink vs. Flaxseed drink consumed and appetite sensation registered over 120 minutes. Hereafter energy intake was measured.

Study II:

Flaxseed drink vs. Flaxseed tablets+control drink consumed and appetite sensation registered over 120 minutes. Hereafter energy intake was measured.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Prevention
Appetite
  • Dietary Supplement: Flaxseed drink
    Drink containing flaxseed mucilage
  • Dietary Supplement: Flaxseed tablet
    Tablets containing flaxseed mucilage consumed with a control drink
  • Dietary Supplement: Control drink
    Control drink
  • Placebo Comparator: Study I: control drink
    Intervention: Dietary Supplement: Control drink
  • Experimental: Study I: flaxseed drink
    Intervention: Dietary Supplement: Flaxseed drink
  • Active Comparator: Study II: flaxseed drink
    Intervention: Dietary Supplement: Flaxseed drink
  • Experimental: Study II: flaxseed tablets
    Intervention: Dietary Supplement: Flaxseed tablet
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
45
December 2010
August 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • healthy adults
  • 18-40 years
  • BMI 19-28

Exclusion Criteria:

  • smoking
  • pregnancy or lactation
  • excessive exercise
  • medication (oral contraceptives the only exception)
Both
18 Years to 40 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT01238744
B271
No
Mette Kristensen, Ass Prof, Department of Human Nutrition, University of Copenhagen
University of Copenhagen
Not Provided
Not Provided
University of Copenhagen
August 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP